Wed. 15 May 2024, 8:45am ET
Benzinga
Earnings, Earnings Misses, News
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate of $(0.35) by 525.71 percent. This is a 20.36 percent increase over losses of $(2.75) per share from the same period last year.